Equity Brief · Healthcare2026-05-20
MDT·Healthcare

Medtronic PLC

I · Análisis con IA

En breve

Medtronic manufactures and sells medical devices across four main areas: heart devices like pacemakers and heart valves, neuroscience products including spinal implants and brain stimulation systems, surgical tools including robotic-assisted surgery platforms, and diabetes management products like insulin pumps and glucose monitors [Company Overview]. The company serves hospitals, physicians, and patients in over 150 countries worldwide.

Medtronic is a major medical device company that makes cardiac devices, spinal implants, surgical tools, and diabetes management systems. The company faces moderate financial health concerns with slowing growth and operational inefficiencies [Yahoo Finance], but it maintains a 48-year dividend growth streak and is investing in AI-powered surgical robotics [Yahoo Finance]. Recent news highlights leadership changes in key divisions and positive momentum in new therapy development [Simply Wall St, Yahoo Finance].

Medtronic shows moderate financial concerns with slow growth and modest returns despite strong cash flow generation.

En breve AI analysisConfianza 7/10

Puntuación Sentinellis

5.3/10

Moderate concerns

Capitalización bursátil

$100.9B

Ingresos (12 meses)

$33.5B

II · Noticias recientes

Qué movió el precio

6 stories · ranked by relevance

  • macro2026-05-18

    Mental Health Matters at Medtronic. Explore Our Employee Benefits

    Yahoo Finance

  • macro2026-05-19

    Medtronic Neuroscience Appointment Puts Focus On Execution And Growth Risks

    Simply Wall St

  • macro2026-05-18

    Medtronic (MDT) Advances While Market Declines: Some Information for Investors

    Yahoo Finance

  • macro2026-05-18

    Middle East and Africa Wearable Injectors Market Trends and Forecast Report 2026-2035 Featuring Amgen, BD, Biocon, Gerresheimer, Insulet, J&J, Medtronic, Roche, West Pharmaceutical, Ypsomed

    Yahoo Finance

  • macro2026-05-17

    A Once-in-a-Decade Opportunity: 1 Stock to Buy Hand Over Fist and Hold for Years

    Yahoo Finance

  • macro2026-05-14

    Should Medtronic’s AVIM Hypertension Trial Shift Require Action From Medtronic (MDT) Investors?

    Yahoo Finance

Premium · gratis con cualquier cuenta

Revenue growth of only 3.6% year-over-year is significantly slower than historical medtech sector averages, suggesting Medtronic may be losing competitive ground [Yahoo Finance]

1 de 5 riesgos en este informe

Riesgos

5

Oportunidades

6

Señales de alerta

3

Dirección

10

23 hallazgos más en el informe completo — gratis con cualquier cuenta.

Desbloquea el análisis completo de Medtronic PLC

Crea una cuenta gratuita para acceder al informe completo generado con IA, con fuentes citadas en el texto.

  • 5 riesgos, 6 oportunidades y 3 señales de alerta — cada uno con su fuente
  • Más de 100 métricas financieras con gráficos y comparativas
  • Resúmenes completos de noticias con enlaces a las fuentes
  • Equipo directivo y remuneración
  • Exportación a PDF para leer sin conexión
Desbloquea los 14 hallazgos3 informes gratis · sin tarjeta

III · Empresas similares

También te puede interesar

Same sector · Healthcare or comparable health

¿La añades a tu lista?

Read three companies free. Sin tarjeta.

Consigue 3 informes gratis
Medtronic PLC (MDT) Análisis de acciones en lenguaje sencillo — Sentinellis